Mayer, Felix P <br/><br/>
Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter.  [electronic resource] 

 -  Neuropharmacology  04 2019 
 - 199-209 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2018.12.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--pharmacology<br/>Animals<br/>Cells, Cultured<br/>Dopamine Uptake Inhibitors--pharmacology<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Methadone--analogs & derivatives<br/>Mice<br/>Radioligand Assay<br/>Rats<br/>Receptors, Catecholamine--drug effects<br/>Receptors, Serotonin--drug effects<br/>Selective Serotonin Reuptake Inhibitors--pharmacology<br/>Stereoisomerism